Related Experiment Video
Updated: Jul 16, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Heterozygous c.175C>T variant in PURA gene causes severe developmental delay
Yusuke Noda1,2, Jun Kido1,2, Yohei Misumi3
1Department of Pediatrics Kumamoto University Hospital Kumamoto Japan.
Insights
This case report details a child with PURA-related neurodevelopmental disorder due to a specific genetic variant. Even with the same mutation, clinical presentations vary significantly, highlighting the complexity of this condition.
Area of Science:
- Genetics
- Neurodevelopmental Disorders
- Clinical Case Studies
Background:
- PURA-related neurodevelopmental disorder is a rare genetic condition.
- Pathogenic variants in the PURA gene can lead to significant neurodevelopmental challenges.
Observation:
- A case of a child with PURA-related neurodevelopmental disorder caused by the heterozygous pathogenic variant c.175C>T (p.Gln59*) is presented.
- Clinical manifestations included microcephaly, brachygnathia, severe hypotonia, developmental delay, feeding and respiratory difficulties, and regression of development.
- The patient's development at 10 years old was comparable to that of a 6-month-old infant.
Findings:
- The specific variant c.175C>T (p.Gln59*) in the PURA gene was identified as the cause.
- Significant variability in clinical symptoms exists, even among patients with the identical genetic variant.
- The presence or absence of epilepsy and congenital malformations can differ.
Implications:
- This case underscores the phenotypic heterogeneity associated with PURA gene variants.
- Long-term clinical monitoring and individualized medical support are crucial for patients with PURA-related neurodevelopmental disorder.
- Further research is needed to understand the full spectrum of this disorder and its management.
Key Clinical Message:
This case report presents a child with PURA-related neurodevelopmental disorder, caused by the heterozygous pathogenic variant c.175C>T (p.Gln59*). The clinical symptoms included microcephaly, brachygnathia, central and peripheral hypotonia, and developmental delay (non-verbal), among others. On comparison with published literature, even patients with the same mutation present different clinical symptoms.
Abstract:
This case report presents a child with PURA-related neurodevelopmental disorder, caused by the heterozygous pathogenic variant c.175C>T (p.Gln59*), whose symptoms included microcephaly, brachygnathia, the development of a high anterior hairline, hip dysplasia, strabismus, severe hypotonia, developmental delay (non-meaningful verbal), feeding difficulties, and respiratory difficulties. His development ceased with age, such that his development at 10 years corresponded to an infant of 6 months. Moreover, even patients with the same variant can have different clinical symptoms, such as the presence or absence of epilepsy or congenital malformations. Therefore, we should follow his long-term clinical course and provide medical support as necessary.
Related Concept Videos
Incomplete Dominance
Genetic Lingo
Pleiotropy
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Mutations

